Athena operates in the field of human cell therapies using the most up-to-date technologies to deliver Advanced Therapy Medicines Products and Autologous Cell Transplantation Point of care.

The staff and network of scientific collaborations integrate experience and know-how to deliver information, training and technical solutions to specific therapeutic needs.

NEWS

Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no‑option critical limb‑threatening ischemia and severe diabetic foot ulcers

Results of a prospective observational
study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers

Innovative cell therapy in the treatment of the diabetic foot. Dr Alessia Scatena – San Donato Hospital in Arezzo

SkyTG24 3 September, 2021

Cellular therapy with encouraging results at the San Donato Hospital in Arezzo for patients with diabetic foot and critical ischaemia.

Insalutenews.it 2 October, 2021.

At the Vascular Surgery Department of the San Jacopo Hospital in Pistoia, a successful minimally invasive treatment with blood filtered by a Monocells kit.

Reportpistoia.com 31 March, 2022.

Interview with Dr Mario Bellisi, specialist in vascular surgery: Lymphoedema of the lower limbs at the Policlinico Giaccone of Palermo

Insanitas.it Insanitas.it 2 September, 2019

New weapons against Obliterative Arteriopathy: filtered cells extracted from the patient reinoculated that regenerate blood vessels. Professor Gaspare Gulotta, Director of the Department of General Surgery at the Policlinico Paolo Giaccone in Palermo

BlogSicilia.it

Chronic obstructive arteriopathy: in addition to the endovascular method, the use of autologous mononuclear cells is gaining ground in the field of angiogenic treatments.

tagmedicina.it 3 April, 2019

At the IRCCS Neuromed in Pozzilli the Congress ‘The evolution of vascular surgery between present and future’ discussed the new frontier of regenerative medicine for diabetic foot ulcers

adnkronos.com 26 March, 2019

Athena operates in the field of human cell therapies through a platform of integrated expertise. Its staff and network of scientific collaborations integrate experience and know-how to produce information, education and technical solutions to specific therapeutic needs.

Latest partecipations

Events and Partecipation

XVII National Congress

Museo Del Risorgimenton Italiano, Palazzo Carignano, Torino 26-27 September 2022

Read More »

GISM 2022 Annual Meeting

Torino StarHotel Majestic 20-21 October 2022

Read More »

VII Congresso Nazionale SIMCRI

Centro Congressi Federico II, Napoli 21-22 October 2022

Read More »

MISTRAL & CARTILAGE

Santa Teresa Gallura- Cine Teatro Nelson Mandela 26-27 May 2022

Read More »

Giornate di Chirurgia Vascolare VI Congresso Regionale SIFL

Hotel Dei Principati, Baronissi, Salerno. 10,11 June, 2022

Read More »

Il Meeting Sud e Delle isole Maggiori

Alghero, Sala Meeting Hotel Carlos V 16-17 September 2022

Read More »

XIX Congresso Nazionale di Chirurgia Vascolare della SICVE Società Italiana di Chirurgia Vascolare ed Endovascolare

Cagliari 13-15 Ottobre 2021

Location: Cagliari
Date: 13-15 October 2021

Read More »

XI Update Course in Vascular Pathology. Arterial thrombosis and venous thrombosis, similarities and differences at the time of covid. Villa Fiorita, Capua

Caserta, Grand Hotel Vanvitelli 30 October 2021

Place: Grand Hotel Vanvitelli-Caserta
Date: 30 October 2021

Read More »
Products

Athena is present with its therapeutic solutions in laboratories and in more than 40 Italian hospitals, university clinics and I.R.C.S. (Scientific Hospitalization and Treatment Institutes)

SEXTON BIOTECHNOLOGIES

Sexton Biotechnologies is a  biotechnology company focused on the development and sales of bioproduction tools for cell and gene therapy, located in Indianapolis, INDIANA (USA).

Sexton develops purpose-built CGT tools and media to enable flexible automation and scaling of cell manufacturing processes to increase the probability of positive clinical outcomes and reduce time-to-market, failure points, and labor costs. Sexton’s portfolio includes the CellSeal platform of cryo-storage tools and fill/finish systems and human platelet lysate growth supplements

COOK REGENTEC - HemaTrate® Blood Filtration system

HemaTrate® Blood Filtration System (Cook Regentec) is designed for use in the clinical laboratory, or intra-operatively at the point of care, for the rapid preparation of a total nucleated cell concentrate (TNC) from 20-120 ml of anticoagulated blood for use in human cell therapy applications.

The HemaTrate® Blood Filtration System device is contained in the HemaTrate® Procedure Pack produced by Betatex Spa on Athena specifications. HemaTrate® Procedure Pack is a sterile, assembled kit complete with required accessories for product use, supporting consistent procedural technique while considering the patient’s biological variable.

SYMATESE - NEVELIA® Bi-Layer Matrix

NEVELIA® Bi-Layer Matrix is a matrix that serves as a support (scaffold) for the infiltration of patient cells and thus contributes to the natural process of tissue regeneration. The medical grade silicone layer consists of a silicone elastomer reinforced with a polyester material, which acts as a ‘pseudo-epidermis’, protecting the wound from bacterial infection and other damage

Scroll to Top